MedPath

A clinical feasibility study to evaluate the effectiveness and safety of VivescOs™ as bone graft for reconstruction of intra-oral osseous defects

Completed
Conditions
Intra-oral bone defects, loss of teeth/molars
Musculoskeletal Diseases
Registration Number
ISRCTN92152389
Lead Sponsor
IsoTis NV (The Netherlands)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
10
Inclusion Criteria

Repair of the intra-oral defect was indicated as preparation for dental implant placement in a secondary stage.

Exclusion Criteria

1. Presence of local or systemic disease;
2. Pregnancy, cancertherapy;
3. Previous participation in another trial within 30 days;
4. Known hypersensitivity for penicillin, streptomycin.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath